Return to content in this issue

Shortened Up-Dosing With 7 Injections of Subcutaneous Allergy Immunotherapy (Alutard SQ) Is Safe and Well Tolerated

Horn A¹, Fernández-Rivas M², Wolf H³, Ghaussy N³, Møller Kruse T⁴, Koutromanou K⁴, Wüstenberg E<sup>3,5

1</sup>ENT Practice am Neckar, Drs Horn & Choudhry, Heidelberg, Germany
²Allergy Dept, Hospital Clínico San Carlos, IdISSC, ARADyAL, Madrid, Spain
³Medical Department ALK-Abelló Arzneimittel GmbH, Hamburg, Germany
⁴ALK Global Pharmacovigilance and Clinical Development, Hørsholm, Denmark
⁵ENT Clinic Medical Faculty Carl-Gustav-Carus, Technical University, Dresden, Germany

J Investig Allergol Clin Immunol 2021; Vol 31(1) : 80-83
doi: 10.18176/jiaci.0561

• Abstract
• Supplemental Materials

Key words: Adverse events, Safety, Short up-dosing, Subcutaneous allergy immunotherapy, Tolerability

	Title	Type	Size
	doi10.18176_jiaci.0561_material-suppl.pdf	pdf	1.08 Mb